Source: Annual Congress 2010 - Acute lung injury: barrier properties and leukocyte activation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Oikonomou, A. Thanassopoulou, A. Kotanidou, G. D. Prestwich, V. Aidinis (Athens, Greece; Salt Lake City, United States Of America). LSC 2010 Abstract: Genetic or pharmacologic inhibition of ATX stimulates LPS-induced pulmonary inflammation. Eur Respir J 2010; 36: Suppl. 54, 2113

Member's Comments

No comment yet.

Related content which might interest you: Oral presentation: Genetic or pharmacologic inhibition of ATX stimulates LPS-induced pulmonary inflammation Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 cPLA2alpha inhibitor ASB14780 suppresses airway MMP-9 production and improves respiratory function in cigarette-smoke induced model Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Maintenance of IRF1 by MAPK inhibition: A mechanism by which DUSP1 reduces glucocorticoid inhibition of CXCL10 Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 LSC 2010 Abstract: Exogenous administration of leptin restores the skewed inflammatory response in cigarette smoke-exposed ob/ob mice Source: Annual Congress 2010 - Stem cells and growth factors in lung injury Year: 2010 AZD7624, an inhaled p38 inhibitor for COPD, attenuates lung and systemic inflammation after LPS Challenge in humans Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 Synergistic effects of p38 MAPK inhibition with a corticosteroid in alveolar macrophages from corticosteroid insensitive asthma patients Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 Inhibition of LPS-induced cytokine/chemokine production from human lung macrophages by roflumilast is enabled by autocrine PGE2 Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010 Inhibition by roflumilast vs cilomilast of pulmonary leukocyte accumulation and TNFα release in a rat model of LPS-induced pulmonary neutrophilia Source: Eur Respir J 2003; 22: Suppl. 45, 107s Year: 2003 The anti-inflammatory effects of sulforaphane are not mediated by the Nrf2 pathway Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Stimulation of IL-8 release in respiratory cell cultures by increasing IL1-beta concentrations: Effect of budesonide Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 LATE-BREAKING ABSTRACT: Roflumilast and its active metabolite inhibit LPS-induced cytokines production from human parenchymal and bronchial explants: interaction with formoterol Source: Annual Congress 2009 - Airway cell biology Year: 2009 LSC 2010 Abstract: Macrophages promote proliferation of lung cancer cell by activation of NF-κB Source: Annual Congress 2010 - New insights in the pathology of lung cancer Year: 2010 Rapamycin inhibits IL-33-induced airway inflammation Source: Annual Congress 2011 - Asthma mechanisms Year: 2011 LSC 2010 Abstract: Creatine supplementation upregulates chronic allergic airway inflammation and remodeling via activation of epithelial cells Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010 Role of ADAM17 in endotoxin-induced pulmonary inflammation Source: Annual Congress 2011 - Barrier functions in sepsis and acute lung injury Year: 2011 Inhibition of HGF secretion by pulmonary fibroblasts from IPF: involvement of PGE2 Source: Eur Respir J 2003; 22: Suppl. 45, 8s Year: 2003 Decreased PTEN amplifies PI3K signaling and enhances pro-inflammatory cytokine release in COPD Source: International Congress 2016 – Studies in airway cell biology Year: 2016 LSC 2010 Abstract: Overexpression of Ang-(1-7)-fusion protein in the lungs prevents pulmonary fibrosis and accompanying pulmonary hypertension Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010 Inhibition of phosphodiesterase 4B enhances glucocorticoid-dependent gene transcription in human airway epithelial cells: Implications for the treatment of COPD Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 LSC 2010 Abstract: Acute lung inflammation in response to carbon nanoparticle exposure is augmented in the absence of NF-kB Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010